Note: Ingredients listed on restricted chemical lists
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
≥10-<20 %
EC/CAS
271-846-8/68609-97-2
Name of the chemical
Oxirane, mono[(C12-14-alkyloxy)methyl] derivs
Concentration
00-2
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
00-4
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
≥1-<3
General Information
Version
5
Revision date
2024-11-22
Product name
FUGALITE BIO PARQUET (A)
1.2.2. Uses advised against
All uses other than recommended ones; Not intended for use by private individuals or non-professionals
Emergency telephone
01 809 2166, +356 2395 2000
Icons in SDS
Company Information
company name
KERAKOLL S.p.A
e-mail address of the competent person responsible for the Safety Data Sheet
safety@kerakoll.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H360F, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No other hazards
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H360F May damage fertility. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves and eye protection. P280 Wear protective gloves and eye protection. P302+P352 IF ON SKIN: Wash with plenty of water. P305+P351+P33 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy 8 to do. Continue rinsing. P308+P313 IF exposed or concerned: Get medical advice/attention. P501 Dispose of contents/container in accordance with applicable regulations.
Contains
oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 1-Methyl 1,2,2,6,6-pentamethylpiperidin-4- yl decanedioate bis(1,2,2,6,6- pentamethylpiperidin-4-yl) decanedioate bis-[4-(2,3-epoxipropoxi)phenyl]propane
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
None.
2.3 Other hazards
No PBT, vPvB or endocrine disruptor substances present in concentration >= 0.1% No other hazards
